Furthermore, the mutation rate of the MLH1 gene in MPC was significantly higher than that in non-MPC (14% vs. 1%, p < 0.05) in TCGA-SKCM, but there was no significant difference in the POLE and PMS2 genes (Fig. 6C). The gene discussed is PMS2; the disease is myopericytoma.